Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-08-28

Clinical Trial Update: Prediction of Severity of Liver Disease Non Alcoholic Fatty Liver Disease in Patients With Suspected NAFLD by a 13C Octanoate Breath Test [NA]

View source ↗

Summary

This clinical trial update describes a study using a 13C octanoate breath test to predict the severity of liver disease in patients with suspected non-alcoholic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hadassah Medical Organization | Conditions: NAFLD | NA | Status: UNKNOWN